Drugs / Mimotope P10s-PADRE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01390064 | Jul 2011 → Jul 2018 | breast cancer | University of Arkansas | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mimotope P10s-PADRE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01390064 ↗ |
| Modality | Vaccine | “peptide mimotope-based vaccine” NCT01390064 ↗ |
| Route | Subcutaneous | “via subcutaneous (SC) injection following the schedule” NCT01390064 ↗ |